Document Detail


Recommended changes for T and N descriptors proposed by the International Association for the Study of Lung Cancer - Lung Cancer Staging Project: a validation study from a single-centre experience.
MedLine Citation:
PMID:  19692259     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
OBJECTIVE: The International Association for the Study of Lung Cancer (IASLC) recently recommended changes for T and N descriptors for the next TNM (Tumour, Node, Metastasis) edition. We re-classify our operated patients to evaluate the effectiveness of the IASLC suggestions. METHODS: IASLC proposals include: (1) a subdivision of T1 into T1a (< or =2 cm) and T1b (2-3 cm); (2) a subdivision of T2 into T2a (3-5 cm) and T2b (5-7 cm); (3) a re-assignment of T2 >7 cm to T3; (4) a re-assignment of intrapulmonary metastasis in the primary lobe (PM1) and in ipsilateral different lobes (PM2) from T4 to T3 and from M1 to T4, respectively; and (5) a classification of N descriptor by the number of involved lymph node zones into: N0; single-zone N1 (N1a); multiple-zone N1/single-zone N2 (N1b/N2a) and multiple-zone N2 (N2b). From 1994 to 2007, 1805 patients were operated on for non-small-cell lung carcinoma (NSCLC); survival analysis was performed using Cox proportional hazard model to assess the prognostic significance of the T and N descriptors. RESULTS: Stratification by T descriptor was: T1a (362 patients), T1b (286), T2a (536), T2b (154), T2 >7 cm (58), T3 (243), PM1 (50) and PM2 (36). Stratification by N descriptor was: N0 (1150 patients), N1a (289), N1b/N2a (200) and N2b (67). A significant survival difference was found between T1a and T1b (hazard ratio (HR) 1.45, 95% confidence interval (CI): 1.10-1.90, p=0.006) but not between T2a and T2b (HR: 1.11, 95% CI: 0.86-1.43, p=0.38). Tumours >7 cm and PM1 had a survival similar to other T3 tumours (HR: 1.05, 95% CI: 0.97-1.14, p=0.2 and HR: 0.99, 95% CI: 0.81-1.21, p=0.94). An excellent patient stratification was provided with the proposed four-category nodal grouping, with significant survival differences between N0 and N1a (HR: 1.81, 95% CI: 1.50-2.21, p=0.0000001), N1a and N1b/N2a (HR: 1.54, 95% CI: 1.21-2.00, p=0.02) and between N1b/N2a and N2b (HR: 1.61, 95% CI: 1.14-2.27, p=0.02). CONCLUSIONS: Our experience confirms the IASLC recommendations to subdivide patients by tumour size at 2, 3 and 7 cm, to re-assign PM1 tumours to T3 and to group patients according to the number of involved lymph nodal zones are valid and provide excellent survival stratification.
Authors:
Enrico Ruffini; Pier Luigi Filosso; Maria Cristina Bruna; Francesco Coni; Riccardo Carlo Cristofori; Claudio Mossetti; Paolo Solidoro; Alberto Oliaro
Related Documents :
18240919 - Comparative risk of leptomeningeal disease after resection or stereotactic radiosurgery...
15022289 - Salvage chemotherapy with cyclophosphamide for recurrent, temozolomide-refractory gliob...
18036819 - Multiagent chemotherapy studied in a xenograft model of medulloblastoma/primitive neuro...
20334979 - Can chemotherapy concomitantly delivered with radiotherapy improve survival of patients...
19904559 - Effect of bevacizumab in older patients with metastatic colorectal cancer: pooled analy...
9655289 - Unique features of gastric carcinoma in the young: a population-based analysis.
15897739 - A proposal for a new and more practical grading scheme for pancreatic ductal adenocarci...
12640499 - Vertical growth phase and positive sentinel node in thin melanoma.
3661489 - Aminothiadiazole (nsc #4728) in patients with advanced colon cancer. a phase ii study o...
Publication Detail:
Type:  Journal Article     Date:  2009-08-18
Journal Detail:
Title:  European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery     Volume:  36     ISSN:  1873-734X     ISO Abbreviation:  Eur J Cardiothorac Surg     Publication Date:  2009 Dec 
Date Detail:
Created Date:  2009-11-25     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8804069     Medline TA:  Eur J Cardiothorac Surg     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  1037-44     Citation Subset:  IM    
Affiliation:
Department of Thoracic Surgery, University of Torino and S. Giovanni Battista Hospital, Ospedale Molinette, 3, Via Genova 10126, Turin, Italy. enrico.ruffini@unito.it
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Cardiopulmonary bypass with physiological flow and pressure curves: pulse is unnecessary!
Next Document:  Applicability of the revised International Association for the Study of Lung Cancer staging system t...